Francesco Patitucci

Dr. Francesco Patitucci

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MDMarco Dattilo
Marco Dattilo
FPFrancesco Patitucci
Francesco Patitucci
SPSabrina Prete
Sabrina Prete
Ortensia Ilaria ParisiOrtensia Ilaria Parisi
Ortensia Ilaria Parisi
Puoci PuociPuoci Puoci
Puoci Puoci
Hydrogels are three-dimensional crosslinked structures with physicochemical properties similar to the extracellular matrix (ECM). By changing the hydrogel’s material type, crosslinking, molecular weight, chemical surface, and functionalization, it is possible to mimic the mechanical properties of native tissues. Hydrogels are currently used in the biomedical and pharmaceutical fields for drug delivery systems, wound dressings, tissue engineering, and contact lenses. Lately, research has been focused on hydrogels from natural sources. Polysaccharides have drawn attention in recent years as a promising material for biological applications, due to their biocompatibility, biodegradability, non-toxicity, and excellent mechanical properties. Polysaccharide-based hydrogels can be used as drug delivery systems for the efficient release of various types of cancer therapeutics, enhancing the therapeutic efficacy and minimizing potential side effects. This review summarizes hydrogels’ classification, properties, and synthesis methods. Furthermore, it also covers several important natural polysaccharides (chitosan, alginate, hyaluronic acid, cellulose, and carrageenan) widely used as hydrogels for drug delivery and, in particular, their application in cancer treatment.

Verified
Journal Article
Open access
PDF file
SPSabrina Prete
Sabrina Prete
MDMarco Dattilo
Marco Dattilo
FPFrancesco Patitucci
Francesco Patitucci
GPGiuseppe Pezzi
Giuseppe Pezzi
Ortensia Ilaria ParisiOrtensia Ilaria Parisi
Ortensia Ilaria Parisi
Puoci PuociPuoci Puoci
Puoci Puoci
Biomaterials are at the forefront of the future, finding a variety of applications in the biomedical field, especially in wound healing, thanks to their biocompatible and biodegradable properties. Wounds spontaneously try to heal through a series of interconnected processes involving several initiators and mediators such as cytokines, macrophages, and fibroblasts. The combination of biopolymers with wound healing properties may provide opportunities to synthesize matrices that stimulate and trigger target cell responses crucial to the healing process. This review outlines the optimal management and care required for wound treatment with a special focus on biopolymers, drug-delivery systems, and nanotechnologies used for enhanced wound healing applications. Researchers have utilized a range of techniques to produce wound dressings, leading to products with different characteristics. Each method comes with its unique strengths and limitations, which are important to consider. The future trajectory in wound dressing advancement should prioritize economical and eco-friendly methodologies, along with improving the efficacy of constituent materials. The aim of this work is to give researchers the possibility to evaluate the proper materials for wound dressing preparation and to better understand the optimal synthesis conditions as well as the most effective bioactive molecules to load.

Verified
Journal Article
Open access
PDF file
Ortensia Ilaria ParisiOrtensia Ilaria Parisi
Ortensia Ilaria Parisi
FFFabrizio Francomano
Fabrizio Francomano
MDMarco Dattilo
Marco Dattilo
FPFrancesco Patitucci
Francesco Patitucci
SPSabrina Prete
Sabrina Prete
Puoci PuociPuoci Puoci
Puoci Puoci
Molecular recognition is a useful property shared by various molecules, such as antibodies, aptamers and molecularly imprinted polymers (MIPs). It allows these molecules to be potentially involved in many applications including biological and pharmaceutical research, diagnostics, theranostics, therapy and drug delivery. Antibodies, naturally produced by plasma cells, have been exploited for this purpose, but they present noticeable drawbacks, above all production cost and time. Therefore, several research studies for similar applications have been carried out about MIPs and the main studies are reported in this review. MIPs, indeed, are more versatile and cost-effective than conventional antibodies, but the lack of toxicity studies and their scarce use for practical applications, make it that further investigations on this kind of molecules need to be conducted.

5 September 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CFClaudia Ferraro
Claudia Ferraro
MDMarco Dattilo
Marco Dattilo
FPFrancesco Patitucci
Francesco Patitucci
SPSabrina Prete
Sabrina Prete
GSGiuseppe Scopelliti
Giuseppe Scopelliti
Puoci PuociPuoci Puoci
Puoci Puoci
Drug delivery systems (DDSs) represent an emerging focus for many researchers and they are becoming progressively crucial in the development of new treatments. Great attention is given to all the challenges that a drug has to overcome during its journey across barriers and tissues and all the pharmacokinetics modulations that are needed in order to reach the targeting sites. The goal of these pathways is the delivery of drugs in a controlled way, optimizing their bioavailability and minimizing side effects. Recent innovations in DDSs include various nanotechnology-based approaches, such as nanoparticles, nanofibers and micelles, which provide effective targeted delivery and sustained release of therapeutics. In this context, protein-based drug delivery systems are gaining significant attention in the pharmaceutical field due to their potential to revolutionize targeted and efficient drug delivery. As natural biomolecules, proteins offer distinct advantages, including safety, biocompatibility and biodegradability, making them a fascinating alternative to synthetic polymers. Moreover, protein-based carriers, including those derived from gelatin, albumin, collagen, gliadin and silk proteins, demonstrate exceptional stability under physiological conditions, and they allow for controlled and sustained drug release, enhancing therapeutic efficacy. This review provides a comprehensive overview of the current trends, challenges, and future perspectives in protein-based drug delivery, focusing on the types of proteins adopted and the techniques that are being developed to enhance their functionality in terms of drug affinity and targeting capabilities, underscoring their potential to significantly impact modern therapeutics.

11 January 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
FPFrancesco Patitucci
Francesco Patitucci
MMMarisa Francesca Motta
Marisa Francesca Motta
MDMarco Dattilo
Marco Dattilo
RMRocco Malivindi
Rocco Malivindi
ALAdele Elisabetta Leonetti
Adele Elisabetta Leonetti
Puoci PuociPuoci Puoci
Puoci Puoci
Traditional wound dressings may lack suitability for diverse wound types and individual patient requirements. In this context, this study aimed to innovate wound care by developing a 3D-printed patch using alginate and pectin and incorporating Olive Leaf Extract (OLE) as an active ingredient. Different polymer-to-plasticizer ratios were systematically examined to formulate a printable ink with optimal viscosity. The resultant film, enriched with OLE, exhibited a substantial polyphenolic content of 13.15 ± 0.41 mg CAE/g, showcasing significant antioxidant and anti-inflammatory properties. Notably, the film demonstrated potent scavenging abilities against DPPH, ABTS, and NO radicals, with IC50 values of 0.66 ± 0.07, 0.47 ± 0.04, and 2.02 ± 0.14 mg/mL, respectively. In vitro release and diffusion studies were carried out and the release profiles revealed an almost complete release of polyphenols from the patch within 48 h. Additionally, the fabricated film exhibited the capacity to enhance cell motility and accelerate wound healing, evidenced by increased collagen I expression in BJ fibroblast cells. Structural assessments affirmed the ability of the patch to absorb exudates and maintain the optimal moisture balance, while biocompatibility studies underscored its suitability for biomedical applications. These compelling findings endorse the potential application of the developed film in advanced wound care, with the prospect of tailoring patches to individual patient needs.

4 February 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
FPFrancesco Patitucci
Francesco Patitucci
MMMarisa Francesca Motta
Marisa Francesca Motta
OMOlga Mileti
Olga Mileti
MDMarco Dattilo
Marco Dattilo
RMRocco Malivindi
Rocco Malivindi
FPFrancesco Puoci
Francesco Puoci
Burn wounds remain a major clinical challenge due to the limitations of traditional dressings, which often fail to address the diverse needs of patients and varying wound types. This study aimed to advance burn care by developing a 3D-printed patch incorporating natural bioactive compounds from bromelain and aloe vera. The patch was formulated using pre-crosslinked chitosan and alginate hydrogels to ensure suitability for 3D printing and subsequent use. Rheological analysis revealed weak gel behaviour and shear-thinning properties, ensuring excellent printability. The patches exhibited outstanding swelling behaviour and controlled degradation (30 %), alongside notable antioxidant and anti-inflammatory potential, with a polyphenolic content of 1.43 ± 0.07 mg CAE/g and effective scavenging of DPPH, ABTS, and NO radicals, with IC50 values of 29.51 ± 0.30, 10.31 ± 0.28, and 5.94 ± 0.42 mg/mL, respectively. Bioactive compounds from bromelain were consistently released across various pH levels, supporting their therapeutic efficacy. Cell viability studies confirmed strong support for cell growth, while in vitro scratch tests demonstrated biocompatibility and promotion of wound closure. Histological analysis of ex vivo burn models revealed cellular necrosis and protein denaturation characteristic of burn wounds. Application of the patches significantly improved epidermal morphology and enhanced proliferation markers such as Ki67 and α-SMA, indicative of accelerated wound healing. While further clinical validation is needed, these findings underscore the potential of the 3D-printed patches as an innovative solution for burn wound care, offering improved bioactive delivery and enhanced healing outcomes compared to conventional dressings.